Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
11.04.2022 - At the AACR Annual Meeting 2022, Bruker Corporation (Nasdaq: BRKR) launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics cancer research. This press release ...
Bioscience Cellscape Ambergen Miralys Michaell Easterling Ambergen Inc Imaging Life Sciences Mass Spectrometry Business Wire
Source: wallstreet-online.de